The Board of IVD Australia is elected by the membership from among the Corporate Representatives of Member Companies. Board Members are elected for a 2 year term and appoint a Chair, Vice-Chair and Treasurer from among their number to serve a 1 year Term.
Current Office Bearers
Mr Sebastian D’Angelo
General Manager, Laboratory Diagnostics Division, Siemens Healthcare – Australia & New Zealand.
Sebastian has over 30 years’ experience within the Australian IVD industry, having worked as a medical scientist in public pathology laboratories before moving to senior roles at Chiron Diagnostics and Bayer Diagnostics and now at Siemens Healthcare Diagnostics.
Sebastian holds a Bachelor of Applied Science (MLS) degree from RMIT University and a Master of Marketing degree from the Melbourne Business School. He is a Member of the Australian Institute of Company Directors.
Mr John Crothers
Regional Director, Abbott Diagnostics Pty Ltd.
John Crothers is the Regional Director for Australia and New Zealand. Prior to the role in Australia, John was the Commercial Director for Asia Pacific and has also had several years in US Marketing. With over 25 years’ experience in the pathology industry in both the laboratory and IVD, the appreciation of the value of the industry in healthcare is a passion that John continues to pursue.
John has a BSc(MLS) from RMIT and a Graduate Diploma in Business Administration from Swinburne University.
Mr Tristan Duggan
Managing Director, Diagnostic Solutions Pty Ltd
Tristan has over 15 years’ experience in the healthcare industry having worked in both large multinational corporate environments as well as independent distribution organisations. Tristan possesses a Bachelor of Business Management and his career roles have varied across sales, marketing, operations and management. Diagnostic Solutions is owned by Diploma Healthcare who also own Big Green Surgical and both companies operate in Australia and New Zealand.
Mr Jim Kakaflikas
General Manager, QIAGEN
Jim is Director, Head of Commercial Operations at QIAGEN Pt Ltd and on the QIAGEN Leadership team for Asia Pacific. Prior to joining QIAGEN, Jim was the Enterprise Director at Abbott Diagnostics and was responsible for managing business development for Australia and New Zealand. At Abbott Diagnostics., Jim was also a Director for Global Accounts, working with key customer groups in Europe and the USA. Jim has over 25 years’ experience in the In-vitro Diagnostics and healthcare markets, having also worked in a variety of senior marketing, sales and support roles at GlaxoSmithKline and Bayer Diagnostics. Jim started his career as a Medical Scientist in Haematology.
Jim holds a Masters of Business Administration (Australian Graduate School of Management / UNSW) and a Bachelor of Applied Science (MLS) degree from RMIT University.
Mr David Basseal
David is the Business Director, Australia & New Zealand, BD Diagnostics
David Basseal has over 20 years industry experience in Life Sciences with 10 years specifically in In-Vitro Diagnostics. David commenced his career as a scientific researcher in the field of proteomics. He entered the commercial arena with Bio-Rad Laboratories Australia/New Zealand and held positions of increasing responsibility over a 7 year period.
Today David is the Business Director for Diagnostics for Australia/New Zealand at Becton Dickinson (BD). This involves the management of two business segments within BD – Pre-Analytical Systems (PAS) and Diagnostics Systems (DS)
David holds a Master of Business Administration (Australian Graduate School of Management), a Master of Commerce (University of Sydney) and a Bachelor of Medical Science (Honours) (University of Sydney).
Mr Ted Maione
General Manager, Werfen
Ted is the General Manager of Werfen in Australia, moving from the Boston area of United States three years ago.
Ted's career in the IVD industry has spanned the last thirty years, the first twenty of which were with Abbott Diagnostics and the last ten years have been with Werfen/IL. During the twenty years at Abbott he held eight positions of greater responsibility in five different cities throughout the United States. Ten years ago Ted was recruited by Werfen/IL to be the Director of Global Marketing, where his team are responsible for product development and marketing IL’s critical care products throughout the world.
Ted holds degrees in economics from Rutgers University.
Mr Rayden Rivett
General Manager, Cepheid Holdings Pty Ltd
Rayden has been continuously involved in the IVD Industry since 1979 working in sales, marketing and senior management. For 15 years he was Managing Director of bioMérieux in Australia and since 2006 has worked in the USA, Asia-Pacific and more recently in establishing Australian subsidiaries for overseas-based IVD companies. Rayden has represented the IVD sector in the past, being a Board member of MIAA (now MTAA) from 1999 to 2006 and its Vice-Chair (2003-2004), a member of their Diagnostic/IVD Standing Committee 1994-2001, member of the Market Development Committee (1997-2003) and its Chair (2000-2002).
Ms Bernadette Snopek
Senior Manager, PERKINELMER Australia
Bernadette has worked in the healthcare industry for over 20 years. She started her career at the Ludwig Institute for Cancer Research in Parkville as an Assistant Laboratory Manager. Several commercial roles in the Life Sciences industry for a decade and the last ten years have been specific to the Diagnostics industry in South East Asia. She has run her own company manufacturing Australian made goods and self-published a book relating to chronic fatigue syndrome/ myalgic encephalomyelitis/ fibromyalgia. The book is an aide for sufferers. Her current corporate role specializes in Molecular Diagnostics and Nucleic Acid Products supporting the regional team. Bernadette has been involved with TGA and all regional company product registrations in various South East Asian countries in her role with PerkinElmer.
Mr Vito Trifilo
General Manager, Tecan Australia
I have over 20 years’ experience in the Life Science and in vitro diagnostic businesses in the Australian and New Zealand markets. I have had held business development and sales management roles for over 10 years and was an early company representative with AMRAD Pharmacia Biotech during the start-up phase. My current role is General Manager at Tecan Australia (a position that I have held for over 2 years), with ANZ sales, marketing, legal and regulatory responsibilities. Tecan is a leading global provider of laboratory instruments and solutions (strongly automation focussed) in biopharmaceuticals, forensics and clinical diagnostics.